Qi-jing Wang
State Key Laboratory Of Oncology In South China, P.R. China
Guangzhou, China
Guangzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications
The efficacy and safety of the combination of axitinib and pembrolizumab-activated autologous DC-CIK cell immunotherapy for patients with advanced renal cell carcinoma: a phase 2 study.
Journal: Clinical & translational immunology
Published: October 15, 2020
CIK cell cytotoxicity is a predictive biomarker for CIK cell immunotherapy in postoperative patients with hepatocellular carcinoma.
Journal: Cancer immunology, immunotherapy : CII
Published: November 08, 2019
Retrospective analysis of the efficacy of cytokine-induced killer cell immunotherapy combined with first-line chemotherapy in patients with metastatic colorectal cancer.
Journal: Clinical & translational immunology
Published: October 13, 2019
PD-L1 expression patterns in tumour cells and their association with CD8+ tumour infiltrating lymphocytes in clear cell renal cell carcinoma.
Journal: Journal of Cancer
Published: August 07, 2018
Safety and activity of PD-1 blockade-activated DC-CIK cells in patients with advanced solid tumors.
Journal: Oncoimmunology
Published: October 20, 2017
Cytotoxic T lymphocyte antigen-4 expression in esophageal carcinoma: implications for prognosis.
Journal: Oncotarget
Published: November 23, 2015
PD-L1 expression as a predictive biomarker for cytokine-induced killer cell immunotherapy in patients with hepatocellular carcinoma.
Journal: Oncoimmunology
Published: October 09, 2015
Last Updated: 09/26/2026